Back to today’s briefing

Story perspectives

23andMe Launches Discover23: Transforming Genetic Research Safely

1/18/2025

50 8

Summary

Story summary

23andMe has unveiled Discover23, a groundbreaking research platform that grants authorized collaborators secure access to its vast genetic database. In partnership with Lifebit, it facilitates genome-wide studies across 1,000 disease cohorts, paving the way for advancements in drug development and precision medicine—all while prioritizing participant privacy. CEO Anne Wojcicki highlights its promise for revolutionary treatments.

1 of 1

Story summary

23andMe has unveiled Discover23, a groundbreaking research platform that grants authorized collaborators secure access to its vast genetic database. In partnership with Lifebit, it facilitates genome-wide studies across 1,000 disease cohorts, paving the way for advancements in drug development and precision medicine—all while prioritizing participant privacy. CEO Anne Wojcicki highlights its promise for revolutionary treatments.